Search Press releases Keywords From To 5 Apr 2024 Acquisition of own shares Read More 4 Apr 2024 FDA Accepts Supplemental Biologics License Applications for BIMZELX[?] (bimekizumab-bkzx) for Moderate to Severe Hidradenitis Suppurativa and Additional 2mL Device Presentations Read More 29 Mar 2024 Share Repurchase Program 2024 to cover 金禾娱乐城's Long Term Incentive Plans for employees Read More 22 Mar 2024 金禾娱乐城 receives positive CHMP opinion for BIMZELX[?]▼(bimekizumab) for the treatment of adults with moderate to severe hidradenitis suppurativa Read More 15 Mar 2024 金禾娱乐城 announces changes on Board of Directors Read More 13 Mar 2024 金禾娱乐城 successfully completes institutional Eurobond issue Read More Pagination First page Previous page Previous … Page 12 Page 13 Page 14 Page 15 Current page 16 Page 17 Page 18 Page 19 Page 20 … Page 16 of 66 Next page Next Last page Stay up-to-date on the latest news and information from 金禾娱乐城 Subscribe
